Elizabeth McKenna
@ElizSMcKenna
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her
ID:24753832
https://aacrjournals.org/cancerdiscovery 16-03-2009 19:42:02
12,7K Tweets
15,6K Followers
5,3K Following
Follow People
Anirban Maitra
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Cancer Discovery
Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.
Iannis Aifantis
Cancer Research & Immunology. Professor and Chair @NYUGSOM_Path @nyugrossman. My Instagram (iannis.aifantis) is more fun. Opinions my own.
Cancer Cell
Cancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.
Ashi_W
Chair, JHBSPH BMB Advocate women/POC in STEM. Wife, mother. Opinions (lots!) mine. She/her. Author: Is Cancer Inevitable? https://t.co/3qWFIzOCEv 🇱🇸🇱🇰
I am quite ecstatic to have been selected as a Senior Editor for Molecular Cancer Research !
In Focus from the May issue—
Insights and opportunity costs in applying spatial biology to study the tumor microenvironment, by Cameron R. Walker and Michael Angelo.
bit.ly/4dtYAb7
Stanford Pathology
Congratulations Santi Demajo Meseguer, Nuria Lopez-Bigas and #CancerGrandChallenges team PROMINENT on their latest paper in Cancer Discovery!
.Nuria Lopez-Bigas: Sanchez-Guixe et al. Cancer Discovery 2024 looks at second malignancies in children who had previous chemotherapy. You can see the mutational signature of the chemo in normal tissues #CancerEvoEco24
“The time of direct targeting KRAS is really upon us now—with many, many different companies and small molecule strategies going after this target” Kevan Shokat @ucsf at #AACR24 | To Conquer KRAS, Drugmakers Take Aim at More Mutations ow.ly/UUt650RAUNN via Cancer Discovery
Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis
Cancer Discovery Elizabeth McKenna abeldavidgp Nuria Lopez-Bigas bbglab @irbbarcelona CIBERONC
aacrjournals.org/cancerdiscover…
Now online in Cancer Discovery: Identification of #ClonalHematopoiesis Driver Mutations through In Silico Saturation Mutagenesis - by Santiago Demajo, Joan Enric Ramis-Zaldivar, abeldavidgp, Nuria Lopez-Bigas and colleagues doi.org/10.1158/2159-8… bbglab @irbbarcelona CIBERONC
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
Cancer Discovery AACR OncoAlert Ethan Cerami Dana-Farber Dana-Farber Data Science OncoDaily #MedEd #MedX #Oncology
doi.org/10.1158/2159-8…
Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases
Cancer Discovery AACR OncoAlert Sara Horie Yuki Saito Keisuke Kataoka Laboratory（片岡 圭亮 研究室） 国立がん研究センター研究所 NCCRI Japan Official Account 国立がん研究センターがんゲノム情報管理センター（C-CAT）
doi.org/10.1158/2159-8…
An encouraging development for #BRAF mutant #lungcancer in Cancer Discovery. Responses seen in pretreated pts with class 1 BRAF mutations (V600E) at full dose. Less efficacy for class II/III, though lower doses used. OncoAlert #LCSM Chat Open Oncology
RAS G12C Inhibitors: Three Birds with One Stone Cancer Discovery Andrew Waters aacrjournals.org/cancerdiscover…
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers Cancer Discovery Andrew Waters Krushna Patra aacrjournals.org/cancerdiscover…
In the Spotlight—
Epigenetic control of cancer cell dormancy and awakening in endocrine therapy resistance, by Arnau Llinas-Bertran, Meritxell Bellet-Ezquerra, and José A. Seoane.
bit.ly/4dyLGbW
Vall d’Hebron Institute of Oncology (VHIO)
Thank you Vanderbilt School of Medicine Basic Sciences for writing a wonderful article on our perspective 'The Hallmarks of Precancer' Cancer Discovery.
medschool.vanderbilt.edu/basic-sciences…